The virulence, pathogenicity and immunogenicity of two pseudorabies virus (PRV) variants were investigated in 3-week-old pigs that had been intranasally infected. Variant M303 (A125,126) lacked amino acids valine (125) and cysteine(126) in an immunodominant antigenic region of glycoprotein I (gI) containing two discontinuous antigenic domains, whereas M304 (A59,60) lacked amino acids glycine(59) and aspartic acid(60) in a continuous antigenic domain. M303 (A125,126) was not virulent for pigs, but M304 (A59,60) was as virulent as wild-type PRV: all pigs died within 8 days of infection. Both gI mutant viruses replicated in the oropharyngeal mucosa, although M304 (A59,60) replicated to higher virus titres than M303 (A125,126), and virus was recovered from various tissues. However, in contrast to M304 (A59,60), M303 (A125,126) was not recovered from any central nervous system (CNS) tissues examined. Thus, the tendency of PRV to locate in the CNS was markedly reduced by deleting amino acids valine(125) and cysteine(126) ofgI. Pigs immunized with M303 were completely protected against challenge infection; no clinical signs of disease were detected, no virus was shed, and no secondary antibody response was detected. Thus, deleting amino acids valine(125) and cysteine(126) in gI decreases virulence and neurotropism and does not affect immunogenicity.
Introduction
Glycoprotein I (gI) is one of at least six glycoproteins present in the envelope of pseudorabies virus (PRV, family Herpesviridae, subfamily Alphaherpesvirinae), the causative agent of Aujeszky's disease (Mettenleiter, 1991) . Although gI is not required for growth of the virus either in vitro or in vivo (Berns et al., 1985; Mettenleiter et at., 1985; Ben-Porat et al., 1986) , all of the numerous field strains so far isolated from pigs possess gI (Van Oirschot, 1989) . Therefore, gI is probably important for survival of PRV in pigs. This glycoprotein affects virulence not only in pigs, but also in mice and chickens (Lomniczi et al., 1984 (Lomniczi et al., , 1987 Berns et aI., 1985; Mettenleiter et al., 1987) . Two recent findings suggest that gI affects virulence by facilitating the transport of virus through the central nervous system (CNS). Card et al. (1991 Card et al. ( , 1992 ) demonstrated that gI is important for the transneuron transport of PRV in rats, and Kimman et al. (1992) suggested that gI is important for the transport of PRV through the porcine CNS.
A major development in the eradication of PRV has been the use of marker vaccines in combination with a serological test that makes it possible to differentiate between infected and vaccinated pigs (Van Oirschot, 1989 . In many parts of the world, vaccines that do not express g! are used to differentiate serologically vaccinated pigs from pigs infected with field virus.
In a recent study, performed in vitro and in vivo (Jacobs et al., 1993) , we found that deleting valine(125) and cysteine(126) from gI reduced the size of plaques and reduced virulence for mice to the same degree as deleting the entire gI protein.
In the present study, we investigated the immunogenicity, virulence and pathogenesis of two gI mutant viruses in pigs. One had a deletion of valine(125) and cysteine(126) (termed M303; A125,126). The other had a deletion of glycine(59) and aspartic acid(60) (termed M304; A59,60) (Jacobs et al., 1990) . A gI strain (M301) was constructed by the introduction of a frameshift. Pigs were intranasally infected and signs of disease and virus shedding in oropharyngeal fluid (OPF) were monitored. Tissue specimens were collected from some pigs for examination of pathology; other pigs were challenged with virulent PRV 19 weeks after primary infection. We found that deleting the amino acids 0001-1716 © 1993 SGM L. Jacobs and others valine(125) and cysteine(126) in gI decreases virulence and neurotropism to the same degree as deleting gI, and does not affect immunogenicity.
Methods
Cell cultures and plaque titration. A pig kidney cell line (SK6) was cultivated in Dulbecco's modified essential medium (DMEM) supplemented with 5 % fetal calf serum (FCS), L-glutamine (0.3 mg/ml), penicillin (90units/ml), streptomycin (100units/ml) and nystatin (45 units/ml). For quantification, virus was plaque-titrated on SK6 cells.
To determine the virus content in OPF, the latter was diluted in DMEM supplemented with 2 % FCS, L-glutamine (0-3 mg/ml), penicillin (90 units/ml), streptomycin (100 units/ml) and nystatin (45 units/ ml). To determine the virus content of tissues, a 10% (w/v) tissue suspension was made in DMEM supplemented with 2 % FCS, the antibiotics mentioned above, and kanamycin (100 gg/ml). Virus was allowed to adsorb for 1 h at 37 °C before the cells were overlaid with 1% methylcellulose in DMEM supplemented with 5% FCS and antibiotics. About 64 h after infection, the overlay was removed and the cells were stained with a solution containing 0.1% amido black, 6 % acetic acid, 0.8% sodium acetate and 8.5% glycerol. Plaques were counted and the virus titres were expressed as log10 p.f.u./g of sample.
Virus strains. The construction of the gI variants was described earlier (Jacobs et al., 1993) . Briefly, we constructed two gI mutants by deleting two amino acids in antigenic domains of PRV gI. M303 (A 125,126) had a deletion of amino acids valine(125) and cysteine(126), which resulted in the loss of the discontinuous antigenic domains C and E. M304 (A59,60) had a deletion of amino acids glycine(59) and aspartic acid(60) which resulted in the loss of the continuous antigenic domain B (Jacobs et al., 1990) . In addition, a gI strain (M301) was constructed by the introduction of 10 nucleotides at amino acid position 124, which resulted in a frameshift. The NIA-3 strain of PRV (McFerran & Dow, 1975) was used as the parent strain for the development of the gI mutant viruses and as the challenge virus in the animal experiments.
Animals. Dutch Landrace pigs (3-week-old) were from the specific pathogen-free herd of the Central Veterinary Institute. The pigs were born from unvaccinated sows. Before the experiments, the pigs had no antibodies directed against PRV. Pigs of different litters were randomly assigned to experimental groups. During the experiments, each group was housed in a separate isolation room and had continuous access to food.
Experimental design. Ten 3-week-old pigs were infected intranasally with 105 p.f.u, of a gI mutant or wild-type PRV. Six pigs were mockinfected with tissue culture medium. The virus suspension (0.5 ml) was administered slowly into each nostril during inhalation. Six days after primary infection, four pigs from each group infected with a gI mutant or wild-type PRV were killed and examined for the presence of virus and lesions in tissues. Nineteen weeks after primary infection the remaining pigs were challenged intranasally with 103 p.f.u, of the seventh cell culture passage of the virulent PRV strain NIA-3. This challenge inoculum contained between 100 and 1000 median infective doses for pigs (de Leeuw & Van Oirschot, 1985) .
Collection of samples. Swab specimens of OPF were collected daily from 1 day before to 10 days after primary infection, and after challenge infection. Swabs were extracted with 4 ml DMEM supplemented with 5 % FCS and antibiotics. To determine the virus content per gram of OPF, the weight of the collected fluid was measured after centrifugation of the swabs. Blood samples were collected every 2 weeks after primary infection and every week after challenge infection.
Clinical signs of disease. These were monitored as described by Kimman et al. (1992) . The period of growth arrest was defined as the number of days needed for the animal to regain its weight as measured on the day of challenge. Fever was defined as a rectal temperature above 40 °C. Respiratory signs were defined as nasal discharge, sneezing, coughing and laboured breathing. Neurological signs were defined as vomiting, itching, ataxia, paralysis, tremor and convulsions.
Virological and serological examinations. The virus content of OPF after primary infection and after challenge infection was determined by titration. Six days after infection, tissue specimens were collected from the trigeminal ganglion, bulbus olfactorius, brain stem, pons cerebri, cerebellum, medulla oblongata, pharyngeal mucosa, nasal mucosa, tonsil, retropharyngeal lymph node, subparotideal lymph node, mandibular lymph node, lung and spleen. A 10 % (w/v) suspension was made in DMEM supplemented with 2 % FCS and antibiotics, and its virus content was titrated. A complement-independent neutralization assay using a specific PRV antiserum made in rabbits was used to confirm that plaques were caused by PRV.
After heat inactivation (1 h at 56 °C) sera were tested for neutralizing antibodies against PRV NIA-3 using a neutralization assay as described by Bitsch & Eskildsen (1976) . Titres were expressed as log10 of the reciprocal of the highest dilution inhibiting the viral c.p.e, in 50 % of the cell cultures. Antibodies directed against gl were detected in a blocking ELISA, as described by Van Oirschot et al. (1988) . Titres were expressed as the reciprocal of the highest serum dilution that blocks the A45 o value by more than 50 %.
Pathological examination. Tissue specimens collected for virus isolation (see above) were also used for examination of pathology. The specimens were fixed in 10 % neutral buffered formalin, embedded in paraffin and cut into 6 lain sections. Viral antigen was detected in an indirect immunoperoxidase assay (Pol et al., 1991) using a polyclonal rabbit serum directed against PRV. Sections were counterstained with haematoxylin for l0 s. Histological examinations of neural tissues included selection of five sections, 1 mm apart.
Results

Virulence of gI mutant viruses
All pigs infected with M304 (A59,60) or wild-type PRV developed respiratory and neurological signs characteristic of PRV infection. They had fever, lost their appetite, lost weight and died. The mean time to death for pigs infected with M304 (A59,60) was 4.4 days (s.D. _+ 1.4), and for pigs infected with wild-type PRV, 5"7 days (S.D. _+ 1-0). In contrast, none of the pigs infected with the gI virus M301 or M303 (A125,126) developed signs of PRV infection. These pigs had no fever, appetite was normal, and they gained weight as did the uninfected control group. Thus, M304 (A59,60) and wild-type PRV were equally virulent for 3-week-old pigs, whereas M303 (A125,126) and M301 (gI) were avirulent.
Virus content in OPF and tissue specimens
Virus was recovered from the OPF of pigs infected with mutants M301 (gI-) or M303 (A125,126) until 10 days after primary infection and from pigs infected with M304 (A59,60) or wild-type PRV until they died from PRV i n f e c t i o n (Table 1 ). All gI m u t a n t s replicated in the o r o p h a r y n g e a l tissue, a l t h o u g h M301 (gI-) a n d M 3 0 3 (A 125,126) always p r o d u c e d virus titres l o w e r t h a n M 3 0 4 (A59,60) a n d wild-type P R V .
Virus 
T a b l e 2. Virus content in tissue specimens (6 days after infection) of 3-week-old pigs intranasally infected with gI mutants of PRV
infection o r f r o m t h o s e w h i c h died o f P R Y infection (Table 2). Virus titres in tissues o f pigs infected w i t h M 3 0 4 (A59,60) o r wild-type P R V were h i g h e r t h a n virus titres in tissues o f pigs infected w i t h M301 ( g I ) or M 3 0 3 (A125,126). I n c o n t r a s t to the o t h e r pigs, virus was
recovered only from trigeminal ganglia and not from the CNS of pigs infected with M301 or M303. Thus, these mutants did not spread to or replicate in the CNS.
Pathogenesis of gI mutant viruses
Mutants M301 (gI-) and M303 (A125,126) both caused focal slight ganglionitis with some degeneration and necrosis of neurons of the trigeminal ganglion and not in the CNS (Fig. 1 a) . In contrast, wild-type PRV and M304 (A59,60) caused ganglionitis with extensive necrosis of neurons in the trigeminal ganglion and in the CNS. Degeneration of neurons was accompanied by perineuronal gliosis and inflammatory infiltrates. Viral antigens of M304 (A59,60) and wild-type virus were detected in the trigeminal ganglion (Fig. 1 b) , the bulbus olfactorius and the cerebellum. No viral antigens of M301 (gI-) and M303 (A125,126) were detected in the trigeminal ganglion or in other parts of the brain.
The results of the indirect immunoperoxidase assay were thus consistent with the virological findings, with exception of the trigeminal ganglion.
Immunogenicity of gI mutant viruses
Mutants M301 (gI-) and M303 (A125,126) both induced a neutralizing antibody response, which increased sharply until 14 days after primary infection (Fig. 2) . Pigs infected with M304 (A59,60) or wild-type PRV died before the first samples could be collected. Two pigs infected with M303 (A125,126) developed a low (~< 4) gI antibody titre. As expected, pigs infected with M301 (gI-) did not develop antibodies against gI. After challenge infection with virulent PRV NIA-3, no virus was recovered from OPF of pigs primarily infected with M301 or M303, they did not develop fever, did not lose appetite, and had no arrest in their growth. In contrast, pigs from the control group showed severe and characteristic signs of PRV infection; they were very dull, had fever for about 5 days (S.D. + 1) and had growth arrest of 14 days (S.D. + 0). Virus was recovered from OPF until 10 days after challenge infection, with a maximum of 5"6 (expressed as log~0 p.f.u./ml OPF) at day 6. Four of the six pigs primarily infected with M301 (gI) had an increase in neutralizing antibody titres of over 10-fold. No increase however, was measured in pigs primarily infected with M303 (A125,126). Even after challenge infection, no antibody response against gI was measured in pigs infected with M301 (gI-). In contrast, the control group of pigs developed gI antibodies within 14 days after challenge infection (titre /> 64). Pigs infected with M303 (A125,126), which had already developed a low gI antibody titre after primary infection, had no increase in gI antibody titre. 
Discussion
The virulence, pathogenicity and immunogenicity of two PRV mutant viruses, each containing mutations in gI, were investigated in 3-week-old pigs. Mutant virus M303 (A125,126) has a deletion of two amino acids in an immunodominant antigenic region, which resulted in the loss of two discontinuous antigenic domains; M304 (A59,60) has a deletion of two amino acids in a continuous antigenic domain. The construction and in vitro characterization of both mutants have been descibed earlier (Jacobs et al., 1993) . In addition, a gI PRV mutant (M301) was constructed by the introduction of a frameshift. Although M301 (gI-) and M303 (A125,126) were not virulent for pigs, M304 (A59,60) and wild-type PRV were highly virulent: all pigs infected with the latter two died within 8 days of infection. Thus, the virulence of PRV for young pigs was eliminated when the amino acids valine(125) and cysteine(126) were deleted. However, when glycine(59) and aspartic acid(60) were deleted, virulence was not affected. These findings confirmed our earlier results in mice (Jacobs et al., 1993) .
Although M304 and wild-type PRV were isolated from brain tissue specimens, M303 and M301 were not; they were isolated only from the trigeminal ganglion.
Glycoprotein gl is clearly important for the uptake of virus, or spread through the CNS; deleting valine(125) and cysteine(126) eliminated this function of gI, and as a consequence decreased the virulence.
All mutants replicated in the oropharyngeal mucosa, although M303 and M301 replicated to a lower titre than M304 and wild-type PRV. It may be that M301 and M303 replicate too inefficiently in the oropharyngeal mucosa to enter the CNS, and/or that they replicate less in neuronal cells, and as a consequence the immune system has more time to clear the virus. However, wildtype PRV is taken up by and transported very efficiently along peripheral nerves to the CNS (Kuypers & Ugolini, 1990; Strack & Loewy, 1990) and, moreover, the shortest route from the site of infection to the CNS is through the bipolar neurons of the olfactory epithelium to the receptor cells in the bulbus olfactorius. Strangely, however, mutants M301 (gF) and M303 (A125,126) were not isolated from the bulbus olfactorius, but from the trigeminal ganglion. Although we did not investigate whether mutants M301 and M303 established latency in the trigeminal ganglion, this will probably occur (Mengeling, 1991) .
Another possible reason to explain why gI mutant viruses are not taken up, and do not spread through the CNS, may be that a specific cell receptor is not recognized by the gI protein of M301 and M303. It is known that neurotropic viruses like PRV exhibit tropism for specific classes of neurons. Lafay et al. (1991) intranasally inoculated mice with rabies virus, another well studied neurotropic virus. Using mutant Av01, which carries a mutation in position 333 of the glycoprotein G, they found that the mutant could not penetrate several categories of neurons. Lafay concluded that this result was related to the inability to recognize receptors of different groups of neurons.
Another possibility is that there is no transfer of mutant viruses M301 and M303 across synapses. The virus has to cross a synapse to move from neuronal cells in the olfactory epithelium to the bulbus olfactorius. In contrast, movement into the trigeminal ganglion does not involve passage across synapses.
Deleting valine(125) or, more likely, cysteine(126), may have disturbed the conformational structure of gI or the gI-gp63 complex. Glycoprotein gI is non-covalently linked to gp63 and this complex forms a functional entity (Zuckermann et al., 1988) . In future experiments we will investigate the capability of the gI protein of mutant M303 (A125,126) to form a complex with gp63.
Deletion of valine(125) and cysteine(126) of gI diminishes the virulence of PRV in mice and pigs to the same degree as the deletion of the entire glycoprotein. Therefore, one or both of these amino acids appear to be essential for the biological function of gI. The amino acids are located in an immunodominant region in pigs. and because this region is well conserved in other herpesviruses, such as varicella-zoster virus, equine herpesvirus type 1 and bovine herpesvirus type 1, it probably has a (conserved) biological function. In rabies virus, neurovirulence is eliminated by a single amino acid mutation at position 333 of the glycoprotein G (Tuffereau et al., 1989; Lafay et al., 1991) . Neurovirulence in the Sabin type 3 oral polio vaccines is eliminated by a serine to phenylalanine mutation in the structural protein VP3 (Westrop et al., 1989) .
Results of the indirect immunoperoxidase assay on tissues of the CNS were consistent with the virological examination, except for the trigeminal ganglia of pigs infected with M301 (gF) and M303 (A125,126) where no viral antigen was detected. However, ganglioneuritis with extensive neuronal necrosis was detected in all pigs, indicating a viral infection. It is possible that the trigeminal ganglion contained too little virus to enable detection of viral antigen.
It was unexpected that two pigs infected with mutant M303 would develop an antibody titre against gI, because the gI ELISA specifically detects antibodies directed against antigenic domains C and E, which were destroyed by the deletion of valine(125) and cysteine(126) (Jacobs et al., 1990 (Jacobs et al., , 1993 . It is possible that steric hindrance caused this blocking effect, particularly because blocking occurs only at a low dilution of the pig serum.
Pigs infected with M301 (gI) and M303 (A125,126) were completely protected against challenge infection. Although four of the six pigs showed a significant rise in neutralizing antibodies after challenge infection, indicating that there had been virus replication, pigs infected with M303 did not show such a rise. However, no virus was recovered from OPF samples, and no antibodies against gI were detected.
In summary, the present data showed that gI is not important for the immunogenicity of PRV. Furthermore, deleting valine(125) and cysteine(126) of gI strongly decreased virulence and neurotropism of PRV for pigs. Further experiments will be directed to determine whether gI recognizes a neuronal receptor or is necessary for the virus to cross synapses.
